Mr Ravi Mathur, CEO, GS1 India
The pharma sector could be incentivized in the budget for adopting global practices & standards which enable counterfeit detection & authentication. The vision of GS1 India is to significantly enhance patient safety through elimination of medication errors, track & trace, product recalls, counterfeit detection & authentication of medicines & medical devices.
The author is the CEO of GS1 India.
(Published 04 July 2019, 12:20 IST)
JOIN US